ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ...

Net cash used by operations was $2.2 million, offset by $3 million of net financings. The performance of Victoria and Utrecht facilities was strong, with inventory building for off-the-shelf products showing positive revenue in Q2.